1. Home
  2. WAY vs AXSM Comparison

WAY vs AXSM Comparison

Compare WAY & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WAY
  • AXSM
  • Stock Information
  • Founded
  • WAY 1999
  • AXSM 2012
  • Country
  • WAY United States
  • AXSM United States
  • Employees
  • WAY N/A
  • AXSM N/A
  • Industry
  • WAY
  • AXSM Biotechnology: Pharmaceutical Preparations
  • Sector
  • WAY
  • AXSM Health Care
  • Exchange
  • WAY Nasdaq
  • AXSM Nasdaq
  • Market Cap
  • WAY 4.4B
  • AXSM 4.4B
  • IPO Year
  • WAY 2024
  • AXSM 2015
  • Fundamental
  • Price
  • WAY $27.01
  • AXSM $94.32
  • Analyst Decision
  • WAY Strong Buy
  • AXSM Strong Buy
  • Analyst Count
  • WAY 10
  • AXSM 14
  • Target Price
  • WAY $28.78
  • AXSM $124.57
  • AVG Volume (30 Days)
  • WAY 469.3K
  • AXSM 401.5K
  • Earning Date
  • WAY 11-10-2024
  • AXSM 11-04-2024
  • Dividend Yield
  • WAY N/A
  • AXSM N/A
  • EPS Growth
  • WAY N/A
  • AXSM N/A
  • EPS
  • WAY N/A
  • AXSM N/A
  • Revenue
  • WAY $863,293,000.00
  • AXSM $291,489,000.00
  • Revenue This Year
  • WAY $16.43
  • AXSM $42.50
  • Revenue Next Year
  • WAY $9.12
  • AXSM $69.28
  • P/E Ratio
  • WAY N/A
  • AXSM N/A
  • Revenue Growth
  • WAY 15.55
  • AXSM 59.73
  • 52 Week Low
  • WAY $20.26
  • AXSM $55.02
  • 52 Week High
  • WAY $28.57
  • AXSM $98.40
  • Technical
  • Relative Strength Index (RSI)
  • WAY N/A
  • AXSM 61.20
  • Support Level
  • WAY N/A
  • AXSM $89.24
  • Resistance Level
  • WAY N/A
  • AXSM $96.71
  • Average True Range (ATR)
  • WAY 0.00
  • AXSM 3.64
  • MACD
  • WAY 0.00
  • AXSM -0.14
  • Stochastic Oscillator
  • WAY 0.00
  • AXSM 70.09

About WAY Waystar Holding Corp. Common Stock

Waystar Holding Corp is a provider of mission-critical cloud technology to healthcare organizations. its enterprise-grade platform transforms the complex and disparate processes comprising healthcare payments received by healthcare providers from payers and patients, from pre-service engagement through post-service remittance and reconciliation. its platform enhances data integrity, eliminates manual tasks, and improves claim and billing accuracy, which results in better transparency, reduced labor costs, and faster, more accurate reimbursement and cash flow. The market for our solutions extends throughout the United States and includes Puerto Rico and other US Territories.

About AXSM Axsome Therapeutics Inc.

Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.

Share on Social Networks: